Life Sciences

Is Postpartum Psychosis a Biological Emergency?
Care Is Postpartum Psychosis a Biological Emergency?

Clinical researchers have identified that certain individuals possess an inherited genetic sensitivity to hormonal shifts at the cellular level, making them more reactive to the postpartum period. This biological vulnerability transforms what is socially depicted as a time of joy into a high-stakes

How Will the New Talent Hub Shape London's Life Sciences?
Workforce How Will the New Talent Hub Shape London's Life Sciences?

The transformation of London from a historically academic center into a vibrant, commercial life sciences titan is currently being propelled by a sophisticated network of hospitals, research labs, and private equity. This momentum is not merely a byproduct of scientific curiosity but a deliberate

California Launches CalRx to Lower Insulin and Drug Costs
Care California Launches CalRx to Lower Insulin and Drug Costs

In the quiet aisles of a Sacramento pharmacy, a small glass vial marked with a minimalist grizzly bear logo signals a historic departure from the traditional profit-driven pharmaceutical model that has long dominated the American healthcare landscape. This unassuming packaging is the vanguard of

How Can We Safely Manage Food and Drug Allergies?
Care How Can We Safely Manage Food and Drug Allergies?

Unnecessary restriction of staple foods based on self-diagnosis rather than clinical testing can lead to severe nutritional deficiencies and developmental delays in growing children. Understanding the underlying mechanisms of an allergy is essential for distinguishing between minor sensitivities

WHO Accredits Gombe Lab for Measles and Rubella Testing
Care WHO Accredits Gombe Lab for Measles and Rubella Testing

The laboratory's successful use of Enzyme-Linked Immunosorbent Assay for serological detection was a key factor in its recent global health certification. This milestone marks a transformative shift in the diagnostic landscape of West Africa, specifically within the Gombe region. For years,

Innovation and Pharma M&A Drive Selective Biotech Recovery
Business Innovation and Pharma M&A Drive Selective Biotech Recovery

The global pharmaceutical sector has officially moved past the era of broad-based valuation recovery to embrace a period where clinical results and scientific integrity dictate market survival. This transformation is most evident in the way capital is now being deployed, moving away from

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later